Pieris Pharmaceuticals
PIRS
#9811
Rank
S$24.42 M
Marketcap
$18.50
Share price
-15.58%
Change (1 day)
-1.78%
Change (1 year)

Operating Margin for Pieris Pharmaceuticals (PIRS)

Operating Margin as of December 2024 (TTM): -59.78%

According to Pieris Pharmaceuticals's latest financial reports and stock price the company's current Operating Margin is -59.78%. At the end of 2022 the company had an Operating Margin of -128.47%.

Operating Margin history for Pieris Pharmaceuticals from 2016 to 2024

Operating Margin at the end of each year

Year Operating Margin Change
2022-128.47%-11.75%
2021-145.58%15.17%
2020-126.41%129.69%
2019-55.03%-40.83%
2018-93.01%42.09%
2017-65.46%-83.14%
2016-388.22%-28.19%
2015-540.63%148.89%
2014-217.22%-32520.02%
20130.67%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
-79.07% 32.27%๐Ÿ‡บ๐Ÿ‡ธ USA
-87.72% 46.74%๐Ÿ‡บ๐Ÿ‡ธ USA
0.62%-101.04%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.